Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole

被引：23
作者：
Lupoli, G [1 ]
Nuzzo, V [1 ]
DiCarlo, C [1 ]
Affinito, P [1 ]
Vollery, M [1 ]
Vitale, G [1 ]
Cascone, E [1 ]
Arlotta, F [1 ]
Nappi, C [1 ]
机构：
[1] UNIV NAPLES FEDERICO II,DEPT MOL & CLIN ENDOCRINOL & ONCOL,NAPLES,ITALY
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 1996年 / 10卷 / 05期
关键词：
hyperthyroidism; osteoporosis; biphosphonate; osteocalcin; bone mineral density;
D O I：
10.3109/09513599609012821
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
High levels of thyroid hormones accelerate bone turnover. The aim of the present study was to evaluate the effects of treatment with alendronate in patients affected by hyperthyroidism and osteoporosis. We studied 40 hyperthyroid patients with bone loss, divided into two groups according to menopausal state. Before treatment and after 6 and 12 months, serum 1 thyroid hormones levels, sevum osteocalcin level and bone mineral density were evaluated. In all patients we observed an increase in bone mineral density after treatment with alendronate, and a corresponding decrease in serum osteocalcin level.
引用
收藏
页码：343 / 348
页数：6
相关论文
共 50 条
[31]   Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis [J].
Stepán, JJ ;
Vokrouhlická, J .
CLINICA CHIMICA ACTA, 1999, 288 (1-2) :121-135
[32]   Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: A prospective study [J].
Lumachi, Franco ;
Camozzi, Valentina ;
Ermani, Mario ;
De Lottod, Federica ;
Luisetto, Giovanni .
SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES, 2007, 1117 :357-361
[33]   Effects of a physical activity program on the urinary collagen crosslinks in pre- and postmenopausal women [J].
Maynar, Marcos ;
Robles, Maria C. ;
Munoz, Diego ;
Alvarez, Jose L. ;
Grijota, Francisco J. ;
Caballero, Maria J. .
JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2017, 57 (1-2) :117-123
[34]   Connection of Depression and Bone Loss in Perimenopausal and Postmenopausal Women [J].
Bistrovic, Ivana Ljubicic ;
Roncevic-Grzeta, Ika ;
Crncevic-Orlic, Zeljka ;
Franciskovic, Tanja ;
Ljubicic, Rudolf ;
Orlic, Anamarija ;
Kapovic, Miljenko .
COLLEGIUM ANTROPOLOGICUM, 2012, 36 (04) :1219-1223
[35]   Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis [J].
Finkelstein, Joel S. ;
Wyland, Jason J. ;
Lee, Hang ;
Neer, Robert M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04) :1838-1845
[36]   Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study [J].
Hejdova, M ;
Palicka, V ;
Kucera, Z ;
Vlcek, J .
PHARMACY WORLD & SCIENCE, 2005, 27 (03) :149-153
[37]   Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women [J].
Han, K ;
Choi, J ;
Moon, I ;
Yoon, H ;
Han, I ;
Min, H ;
Kim, Y ;
Choi, Y .
OSTEOPOROSIS INTERNATIONAL, 1999, 9 (04) :290-295
[38]   Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study [J].
Miroslava Hejdova ;
Vladimir Palicka ;
Zdenek Kucera ;
Jiri Vlcek .
Pharmacy World and Science, 2005, 27 :149-153
[39]   Serum Cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women [J].
Adolf, Daniela ;
Wex, Thomas ;
Jahn, Oliver ;
Riebau, Christian ;
Halangk, Walter ;
Klose, Silke ;
Westphal, Sabine ;
Amthauer, Holger ;
Winckler, Stephan ;
Piatek, Stefan .
MATURITAS, 2012, 71 (02) :169-172
[40]   Alendronate prevents bone loss in Chinese women with osteoporosis [J].
Lau, EMC ;
Woo, J ;
Chan, YH ;
Griffith, J .
BONE, 2000, 27 (05) :677-680
12345